Skip to main content

Table 1 Distribution of patients across clinical factors by data set

From: Identification and characterization of alternative exon usage linked glioblastoma multiforme survival

  

Training data set

Validation data set

  

Number

Percentage

Number

Percentage

Patients

 

250

76.22

78

23.78

Race1

Caucasian

222

88.80

71

91.03

Other

28

11.20

07

8.97

Gender

Females

94

37.60

29

37.18

Males

156

62.40

49

62.82

Therapy2

R

63

25.20

21

26.92

CRT

27

10.80

07

8.97

CRnT

99

39.60

31

39.74

OTHER

35

14.00

10

12.82

NONE

26

10.40

09

11.54

Survival (months)

 

17.46

0.16 - 128

15.02

0.10 – 77.57

  1. 1Race: White Caucasian, and all other race-ethnicity groups.
  2. 2Therapy; R: radiation therapy alone; CRnT: chemotherapy plus radiation and no targeted therapy; CRT: chemotherapy plus radiation and targeted therapy; OTHER: all other therapies; None: no therapy.
Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us